Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Operating Income 2020–2022
Elicio Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Elicio Therapeutics Inc. operating income for the quarter ending March 31, 2023 was -7.8 M, a 46.12% decrease year-over-year.
- Elicio Therapeutics Inc. operating income for the twelve months ending March 31, 2023 was -34.3 M, a 47.67% decrease year-over-year.
- Elicio Therapeutics Inc. annual operating income for 2022 was -23.7 M, a 39.62% decrease from 2021.
- Elicio Therapeutics Inc. annual operating income for 2021 was -39.3 M, a 28.89% decrease from 2020.
- Elicio Therapeutics Inc. annual operating income for 2020 was -55.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Elicio Therapeutics Inc. Operating Income — FAQ
Elicio Therapeutics Inc. (ELTX) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Elicio Therapeutics Inc.'s operating income?
Elicio Therapeutics Inc. (ELTX) reported operating income of -$24M for fiscal 2022.
Where can I see ELTX's operating income history?
The chart and table above show Elicio Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.